UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 4 | April 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 9 Issue 10
October-2022
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2210384


Registration ID:
503573

Page Number

d568-d572

Share This Article


Jetir RMS

Title

Treatment of ST-Segment Elevation Myocardial Infarction

Abstract

Myocardial infarction (MI) is a term used for an event of heart attack which is due to formation of plaques in the interior walls of the arteries resulting in reduced blood flow to the heart and injuring heart muscles because of lack of oxygen supply14. Acute myocardial infarction has traditionally been divided into ST elevation or non-ST elevation myocardial infarction; STEMI results from complete and prolonged occlusion of an epicardial coronary blood vessel and is defined based on ECG criteria while NSTEMI usually results from severe coronary artery narrowing, transient occlusion, or microembolization of thrombus and/or atheromatous material, however, therapies are similar between the two, and the overall management of acute myocardial infarction can be reviewed for simplicity. Acute myocardial infarction remains a leading cause of morbidity and mortality worldwide, despite substantial improvements in prognosis over the past decade. The progress is a result of several major trends, including improvements in risk stratification, more widespread use of an invasive strategy, implementation of care delivery systems prioritising immediate revascularisation through percutaneous coronary intervention (or fibrinolysis), advances in anti-platelet agents and anticoagulants, and greater use of secondary prevention strategies such as statins.15 Treating a STEMI is time-sensitive. That means the faster the treatment, the better the chances for a favourable outcome.

Key Words

Myocardial infarction, STEMI, NSTEMI, ischemia, cardiac troponin.

Cite This Article

"Treatment of ST-Segment Elevation Myocardial Infarction", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.9, Issue 10, page no.d568-d572, October-2022, Available :http://www.jetir.org/papers/JETIR2210384.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Treatment of ST-Segment Elevation Myocardial Infarction", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.9, Issue 10, page no. ppd568-d572, October-2022, Available at : http://www.jetir.org/papers/JETIR2210384.pdf

Publication Details

Published Paper ID: JETIR2210384
Registration ID: 503573
Published In: Volume 9 | Issue 10 | Year October-2022
DOI (Digital Object Identifier):
Page No: d568-d572
Country: Trivandrandrum, Kerala, Iran .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000194

Print This Page

Current Call For Paper

Jetir RMS